JP2024511316A5 - - Google Patents
Info
- Publication number
- JP2024511316A5 JP2024511316A5 JP2023554809A JP2023554809A JP2024511316A5 JP 2024511316 A5 JP2024511316 A5 JP 2024511316A5 JP 2023554809 A JP2023554809 A JP 2023554809A JP 2023554809 A JP2023554809 A JP 2023554809A JP 2024511316 A5 JP2024511316 A5 JP 2024511316A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- amino acid
- domain
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163159051P | 2021-03-10 | 2021-03-10 | |
| US63/159,051 | 2021-03-10 | ||
| US202163227149P | 2021-07-29 | 2021-07-29 | |
| US63/227,149 | 2021-07-29 | ||
| PCT/US2022/019570 WO2022192411A1 (en) | 2021-03-10 | 2022-03-09 | Actrii-alk4 antagonists and methods of treating heart failure |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024511316A JP2024511316A (ja) | 2024-03-13 |
| JP2024511316A5 true JP2024511316A5 (cg-RX-API-DMAC7.html) | 2025-03-14 |
Family
ID=83228302
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023554809A Pending JP2024511316A (ja) | 2021-03-10 | 2022-03-09 | Ａｃｔｒｉｉ－ａｌｋ４アンタゴニスト及び心不全の治療方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250064952A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4305052A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024511316A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230169124A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2022235083A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023018283A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3211507A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023010445A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022192411A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2024336884A1 (en) * | 2023-09-08 | 2026-03-26 | 35Pharma Inc. | Combination therapy with actriib receptor variants and glp-1 agonists |
| WO2025250605A1 (en) * | 2024-05-31 | 2025-12-04 | Eli Lilly And Company | Acvr2a and acvr2b rna interference agents |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA41920B1 (fr) * | 2015-04-06 | 2021-05-31 | Acceleron Pharma Inc | Protéines de fusion de récepteur type i et type ii à bras unique et leurs utilisations |
| MA41919A (fr) * | 2015-04-06 | 2018-02-13 | Acceleron Pharma Inc | Hétéromultimères alk4:actriib et leurs utilisations |
| DK3496739T3 (da) * | 2016-07-15 | 2021-05-10 | Acceleron Pharma Inc | Sammensætninger omfattende actriia-polypeptider til brug i behandlingen af pulmonal hypertension |
| CA3039573A1 (en) * | 2016-10-05 | 2018-04-12 | Acceleron Pharma Inc. | Alk4:actriib heteromultimers and uses thereof |
| GB201620119D0 (en) * | 2016-11-29 | 2017-01-11 | Pharmafox Therapeutics Ag | Compounds |
| JP7669291B2 (ja) * | 2019-05-30 | 2025-04-28 | アクセレロン ファーマ インコーポレーテッド | Ａｃｔｒｉｉ結合性タンパク質及びその使用 |
| JP2023534127A (ja) * | 2020-06-17 | 2023-08-08 | アクセルロン ファーマ インコーポレイテッド | ＡｃｔＲＩＩ－ＡＬＫ４アンタゴニストおよび心不全を処置する方法 |
-
2022
- 2022-03-09 WO PCT/US2022/019570 patent/WO2022192411A1/en not_active Ceased
- 2022-03-09 KR KR1020237034040A patent/KR20230169124A/ko active Pending
- 2022-03-09 CA CA3211507A patent/CA3211507A1/en active Pending
- 2022-03-09 AU AU2022235083A patent/AU2022235083A1/en not_active Abandoned
- 2022-03-09 MX MX2023010445A patent/MX2023010445A/es unknown
- 2022-03-09 US US18/549,474 patent/US20250064952A1/en active Pending
- 2022-03-09 EP EP22767907.3A patent/EP4305052A4/en active Pending
- 2022-03-09 JP JP2023554809A patent/JP2024511316A/ja active Pending
- 2022-03-09 BR BR112023018283A patent/BR112023018283A2/pt unknown
-
2025
- 2025-09-11 AU AU2025230744A patent/AU2025230744A1/en active Pending